1. Home
  2. Clinical Topics
  3. FDA approves mobile app to encourage retention in opioid use disorder recovery programs
Clinical TopicsDrugs and DevicesUncategorizedWeb Exclusives
fda cognitive behavioral therapy

FDA approves mobile app to encourage retention in opioid use disorder recovery programs

Share

On Dec. 10, the FDA approved reSET-O app, a prescription cognitive behavioral therapy designed to encourage those with opioid use disorder to stay in recovery programs.

Read more via U.S. Food & Drug Administration.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts